Nomura analysts project a 6 per cent year-on-year (Y-o-Y) volume growth for the Indian cement industry in FY26F, compared to ...

Nomura cited higher contribution from diabetes drug Sitaglitptin, which offers a market size of around $300-400 million to be the biggest factor in Zydus Life's rating upgrade.

TARIL is undertaking an ambitious capacity expansion program, which will not only make the company India’s largest ...

Shares of several companies including TCS, IndiGo, DLF, IHCL, Swiggy, and Bajaj Auto, among others, will be in the news today ...

Elara Securities has a 'Buy' rating with a target of Rs 1,088 on Tata Motors. Nuvama has 'Reduce' rating on Tata Motors and a ...

Tech stocks soared in 2024, fueled by AI and cutting-edge innovations, but what’s next? As global IT spending surges and data ...

In a report released today, Ryan Zimmerman from BTIG reiterated a Buy rating on Globus Medical (GMED – Research Report), with a price target of ...

BTIG analyst Mark Massaro has reiterated their bullish stance on PSNL stock, giving a Buy rating today.Stay Ahead of the Market:Discover ...

Cohen & Steers Infrastructure Fund's previous appeal has diminished. Learn why UTF CEF might no longer be a strong buy in the ...

A 53-man roster under the salary cap using actual cap numbers with certain parameters, which are below, was assembled at the ...

The biotech group struggled as a whole in 2024, but analysts say the innovation that has always supported the biotech ...

AMD stock is falling today on the heels of bearish coverage from HSBC. The firm issued a rare double downgrade for its rating on the stock and slashed its one-year price target.